Categories Earnings, Health Care

Merck & Co. (MRK) Q4 earnings beat estimates, revenue slightly misses

Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings for the fourth quarter of 2019. However, the company’s sales slightly missed the forecast. The stock declined early Wednesday immediately after the announcement.

Worldwide sales of the drugmaker rose 8% year-over-year to $11.87 billion but fell short of expectations. Excluding foreign exchange impacts, sales grew 9%. The top-line benefitted from the strength of oncology and human health vaccines.

Merck & Co. (MRK) Q4 earnings beat estimates, revenue slightly misses

Net earnings, on an adjusted basis, rose to $1.16 per share from $1.04 per share in the fourth quarter of 2018 and exceeded the market’s forecast.
Unadjusted net income advanced to $2.36 billion or $0.92 per share from $1.83 billion or $0.69 per share last year.

Also see: Vertex Pharmaceuticals Q4 2019 Earnings Snapshot

“As evidenced by our results and our 2020 guidance, Merck had an extraordinary year and is in a position of operational and financial strength. It is this position of strength, born of our focused execution, that gives us the confidence to spin off our Women’s Health, trusted Legacy Brands and Biosimilar products into a new company,” said CEO Kenneth Frazier.

Outlook

Looking ahead, the company expects worldwide sales to be between $48.8 billion and $50.3 billion in fiscal 2020, which includes a negative impact of about 1% from foreign exchange. Full-year unadjusted earnings are expected to be in the range of $4.57 per share to $4.72 per share. The management is looking for adjusted earnings per share of $5.62-$5.77 for the year.

Reorganization

Merck said it is considering a spin-off of its Women’s Health business, trusted legacy brands, and biosimilar products into a new company so as to focus on the “key growth pillars.”

During the quarter, the company’s cancer drug KEYTRUDA obtained FDA approval for use as monotherapy for the treatment of patients with high-risk, non-muscle invasive bladder cancer.

Updates

As part of diversifying its oncology portfolio, the company closed the acquisition of ArQule last month. It also entered into a tie-up with Taiho Pharmaceutical and Astex Pharmaceuticals focused on the development of small-molecule inhibitors against several drug targets.

Related: Merck Q3 2019 Earnings Conference Call Transcript

Merck’s shares dropped during Wednesday’s premarket session, soon after the earnings announcement. The stock had closed the last session higher.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

ADBE Earnings: Adobe Q1 2024 revenue and profit beat estimates

Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in first-quarter 2024 revenue and earnings. The results also surpassed analysts' forecasts. First-quarter revenues came in at $5.18

Earnings Preview: FedEx (FDX) likely to report higher revenue and profit for Q3

FedEx Corporation (NYSE: FDX) delivered positive earnings performance and margin expansion in the first half of fiscal 2024, despite lower revenues. The cargo giant has been on a path of

Key takeaways from Dollar General’s (DG) Q4 2023 earnings report

Shares of Dollar General Corporation (NYSE: DG) fell over 4% on Thursday despite the company delivering better-than-expected earnings results for the fourth quarter of 2023. The top and bottom line numbers

Comments

  1. Pingback: Beverly Bultron
  2. Pingback: Reba Fleurantin
  3. Pingback: MILF Porn
  4. Pingback: Make my essay
  5. Pingback: valentines gift
  6. Pingback: valentine gift
  7. Pingback: Click Here
  8. Pingback: Click Here
  9. Pingback: Click Here
  10. Pingback: Click Here
  11. Pingback: Click Here
  12. Pingback: Click Here
  13. Pingback: Click Here
  14. Pingback: Click Here
  15. Pingback: Click Here
  16. Pingback: Click Here
  17. Pingback: Click Here
  18. Pingback: Click Here
  19. Pingback: Click Here
  20. Pingback: Click Here
  21. Pingback: Click Here
  22. Pingback: Click Here
  23. Pingback: Click Here
  24. Pingback: Click Here
  25. Pingback: Click Here
  26. Pingback: Click Here
  27. Pingback: Click Here
  28. Pingback: spaceros
  29. Pingback: Click Here
  30. Pingback: Click Here
  31. Pingback: Click Here
  32. Pingback: Click Here
  33. Pingback: Click Here
  34. Pingback: Click Here
  35. Pingback: Click Here
  36. Pingback: Click Here
  37. Pingback: Click Here
  38. Pingback: Click Here
  39. Pingback: Click Here
  40. Pingback: Click Here
  41. Pingback: Click Here
  42. Pingback: Click Here
  43. Pingback: Click Here
  44. Pingback: Click Here
  45. Pingback: Click Here
  46. Pingback: Click Here
  47. Pingback: Click Here
  48. Pingback: Click Here
  49. Pingback: Click Here
  50. Pingback: Click Here
  51. Pingback: Click Here
  52. Pingback: Click Here
  53. Pingback: Click Here
  54. Pingback: Click Here
  55. Pingback: Click Here
  56. Pingback: Click Here
  57. Pingback: Click Here
  58. Pingback: Click Here
  59. Pingback: Click Here
  60. Pingback: Click Here
  61. Pingback: Click Here
  62. Pingback: Click Here
  63. Pingback: Click Here
  64. Pingback: Click Here
  65. Pingback: Click Here
  66. Pingback: Click Here
  67. Pingback: Click Here
  68. Pingback: Click Here
  69. Pingback: Click Here
  70. Pingback: Click Here
  71. Pingback: Click Here
  72. Pingback: premium-domains
  73. Pingback: yoga pants
  74. Pingback: Google reviews
  75. Pingback: 2023 Books
  76. Pingback: obituaries
  77. Pingback: dying
  78. Pingback: IRA Empire
  79. Pingback: fue online catalog
  80. Pingback: اقتصاد
  81. Pingback: fue
  82. Pingback: fue
  83. Pingback: Spectrophotometer
  84. Pingback: MSc in pharmacy
  85. Pingback: Family dentistry
  86. Pingback: fue
  87. Pingback: Local
  88. Pingback: الصيادلة
  89. Pingback: Pharmacy's PHD
  90. Pingback: fue
  91. Pingback: Water Bath
  92. Pingback: Admission Process
  93. Pingback: smart systems
  94. Pingback: first term exams
  95. Pingback: bodytones
  96. Pingback: glucotrust
  97. Pingback: livpure
  98. Pingback: Fiverr Earn
  99. Pingback: Fiverr Earn
  100. Pingback: Fiverr Earn
  101. Pingback: Fiverr Earn
  102. Pingback: fiverrearn.com
  103. Pingback: fiverrearn.com
  104. Pingback: fiverrearn.com
  105. Pingback: fiverrearn.com
  106. Pingback: clima para mañana
  107. Pingback: french bulldog
  108. Pingback: aussiedoodle
  109. Pingback: frenchie doodle
  110. Pingback: tom kings kennel
  111. Pingback: blockchain
  112. Pingback: pennsylvania clima
  113. Pingback: future university
  114. Pingback: Fiverr.Com
  115. Pingback: frenchies texas
  116. Pingback: fue
  117. Pingback: Lean
  118. Pingback: FUE
  119. Pingback: Furniture assembly
  120. Pingback: FiverrEarn
  121. Pingback: FiverrEarn
  122. Pingback: Media
  123. Pingback: Coach
  124. Pingback: FiverrEarn
  125. Pingback: FiverrEarn
  126. Pingback: partners
  127. Pingback: livpure reviews
  128. Pingback: frenchie puppies
  129. Pingback: french bulldog
  130. Pingback: Tips
  131. Pingback: FiverrEarn
  132. Pingback: FiverrEarn
  133. Pingback: FiverrEarn
  134. Pingback: live sex cams
  135. Pingback: FiverrEarn
  136. Pingback: FiverrEarn
  137. Pingback: FiverrEarn
  138. Pingback: FiverrEarn
  139. Pingback: FiverrEarn
  140. Pingback: FiverrEarn
  141. Pingback: FiverrEarn
  142. Pingback: FiverrEarn
  143. Pingback: FiverrEarn
  144. Pingback: wix website
  145. Pingback: pharmacy
  146. Pingback: sns
  147. Pingback: Slot Gacor
  148. Pingback: FiverrEarn
  149. Pingback: FiverrEarn
  150. Pingback: prodentim legit
  151. Pingback: cheap sex cams
  152. Pingback: fullersears.com
  153. Pingback: french bulldog buy
  154. Pingback: live sex cams
  155. Pingback: frt trigger
  156. Pingback: 늑대닷컴
  157. Pingback: Slot 3D
  158. Pingback: allgame
  159. Pingback: 918kiss
  160. Pingback: หวย24
  161. Pingback: Korean Skincare
  162. Pingback: pg slot
  163. Pingback: Raahe Guide

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top